Downgrade Alert for Fresenius Medical Care (FMS)
Fresenius Medical Care (NYSE:FMS) was downgraded from Buy to Neutral at UBS today. The stock closed yesterday at $34.27 on volume of 374,000 shares, above average daily volume of 163,000.
Fresenius Medical Care (NYSE:FMS) has potential upside of 4.4% based on a current price of $34.28 and analysts' consensus price target of $35.80. Fresenius Medical Care shares should encounter resistance at the 50-day moving average (MA) of $35.55 and support at its 200-day MA of $33.82.
Fresenius Medical Care share prices have moved between a 52-week high of $37.01 and a 52-week low of $30.75 and closed yesterday at 11% above that low price at $34.28 per share. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has remained constant.
Fresenius Medical Care AG & Co. KGaA offers kidney dialysis services and manufactures and distributes equipment and products used in the treatment of dialysis patients. The Company also offers clinical laboratory testing and diagnostic testing services and provides home infusion, respiratory therapy, ultrasound, and echo-cardiography. Fresenius operates worldwide.
SmarTrend is tracking the current trend status for Fresenius Medical Care and will alert subscribers who have FMS in their portfolio or watchlist when shares have changed trend direction.
Keywords: analyst upgrades/downgrades fresenius medical care